Navigation Links
Discovery in liver cancer cells provides new target for drugs
Date:3/22/2011

Richmond, Va. (March 23, 2011) Researchers at Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) have discovered a novel mechanism in gene regulation that contributes to the development of a form of liver cancer called hepatocellular carcinoma (HCC). Currently, there is virtually no effective treatment for HCC, and this breakthrough identifies a promising new target for therapeutic intervention.

In the journal Hepatology, Devanand Sarkar, M.B.B.S., Ph.D., Harrison Endowed Scholar in Cancer Research at VCU Massey Cancer Center, a Blick scholar and assistant professor in the Department of Human and Molecular Genetics and a member of the VIMM at VCU School of Medicine, describes for the first time how RNA-induced silencing complex (RISC) contributes to the development of liver cancer.

RISC is an important factor in post-transcriptional gene regulation, which occurs between transcription (where DNA is converted to RNA) and translation (where RNA is converted to protein). These processes regulate functions such as cellular growth, division and death. Sarkar and his team identified the proteins AEG-1 and SND1 as factors that increase RISC activity and lead to the development of liver cancer.

For years, Sarkar has been studying the role of AEG-1 in cancer with his collaborator on this research, Paul B. Fisher, M.Ph., Ph.D., Thelma Newmeyer Corman Endowed Chair in Cancer Research at VCU Massey, professor and chair of the Department of Human and Molecular Genetics and director of the VIMM.

"AEG-1 works as a scaffold protein," says Sarkar. "If you think about scaffolding outside of a biological setting, its function is to help facilitate things like construction. In this case, AEG-1 was found to work with another protein, SND1, to provide the scaffold for the formation of RISC. Since both AEG-1 and SND1 are increased in HCC, the net effect is increased RISC activity."

The study clearly identifies SND1 as a novel regulator of liver cancer. As SND1 is a molecule that can be inhibited by drugs, Sarkar's findings open up a novel avenue for treating liver cancer by targeting SND1.

"RISC works by degrading tumor-suppressor mRNAs, which transmit genetic information in a cell that prevents the formation of tumors. This allows other cancer-causing factors to go unchecked and aid tumor growth," says Sarkar. "Since we've shown that RISC activity is higher in cancer cells than normal, healthy cells, we're hopeful that inhibiting SND1 to decrease RISC activity will do little, if any, damage to healthy liver cells while stopping cancer progression."

Sarkar's team is working hard to find the most clinically-relevant SND1 inhibitors. Once these are found, the researchers will need to prove their effectiveness in several more experiments. The ultimate goal is to move these findings to Phase I clinical trials for patients with liver cancer.


'/>"/>

Contact: John Wallace
wallacej@vcu.edu
804-628-1550
Virginia Commonwealth University
Source:Eurekalert

Related medicine news :

1. Finding of long-sought drug target structure may expedite drug discovery
2. New laser technique opens doors for drug discovery
3. LRI awards wide-ranging research grants to drive next generation of scientific discovery in lupus
4. Clinical observation leads to lung cancer discovery
5. New weight loss discovery by Harvard scientists moves us closer to the Pill for obesity
6. Leicester leads on heart attack genetic link discovery
7. Discovery of new gene mutation in schizophrenia offers a new target for drug therapies
8. UT MD Anderson discovery wins 2010 Cozzarelli Prize
9. Biomarker discovery may lead to reliable blood test for ectopic pregnancy
10. Washington Life Sciences Discovery Fund announces grants to commercialize promising technologies
11. Discovery May Explain Why Brain Cancer Is So Hard to Treat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... August 21, 2017 , ... Five chefs from local senior ... Alzheimer’s Family Center. , Guests will be able to vote for their favorite ... Lamb Shank with Fennel Dill Salad, Feta Cheese Sauce & Garlic Pita Crisp, Greek ...
(Date:8/21/2017)... ... August 21, 2017 , ... PIXACORE , an independent full-service agency with ... 100 agencies of the year by MM&M. , This is the first time PIXACORE ... milestone for the agency. PIXACORE’s newfound recognition reflects its steady trajectory of growth ...
(Date:8/21/2017)... Atlanta, GA (PRWEB) , ... August 21, 2017 , ... ... International Design Excellence Awards (IDSA IDEA®) 2017 Ceremony and Gala on Aug. 19, ... Silver in one of the world’s most prestigious and rigorous design competitions. See all ...
(Date:8/20/2017)... Centennial, CO (PRWEB) , ... August 20, 2017 , ... ... in the same household? If so, you may be interested in participating in ... The purpose of this research is to understand more about the relational aspects of ...
(Date:8/19/2017)... ... August 18, 2017 , ... ... Act of 2017, legislation that provides for greater public access to over-the-counter (OTC) ... loss to access OTC hearing aids without being seen by a certified and ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)... July 31, 2017 Three Tru-D SmartUVC robots have ... South Korea . Tru-D, short for "Total Room Ultraviolet Disinfection," is ... after an environmental services (ES) professional cleans the area with traditional cleaning ... Tru-D fights ... "Although the BAACH has a ...
(Date:7/28/2017)... --EnvoyHealth, a Diplomat company, has partnered with Compliance Meds ... a technology designed to improve patient medication adherence. ... solutions and services that help track and improve patients, ... LITE offers medication monitoring and control for patients and ... Records date and time of bottle ...
(Date:7/26/2017)... , July 26, 2017 E.I. Medical ... the Bimini SharkLab to custom design the worlds first ... of sharks in their native habitat. In preparation for ... Discovery Channel,s Shark Week, Dr. Guttridge approached EIMI with ... pregnancy diagnosis directly to hammerhead sharks underwater. ...
Breaking Medicine Technology: